Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HIX2
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 8 |
GO:0043167 | ion binding | 2 | 8 |
GO:0043169 | cation binding | 3 | 8 |
GO:0046872 | metal ion binding | 4 | 8 |
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 169 | 173 | PF00656 | 0.747 |
CLV_NRD_NRD_1 | 110 | 112 | PF00675 | 0.616 |
CLV_PCSK_KEX2_1 | 110 | 112 | PF00082 | 0.606 |
CLV_PCSK_KEX2_1 | 216 | 218 | PF00082 | 0.660 |
CLV_PCSK_PC1ET2_1 | 216 | 218 | PF00082 | 0.573 |
DOC_USP7_MATH_1 | 197 | 201 | PF00917 | 0.742 |
DOC_USP7_MATH_1 | 203 | 207 | PF00917 | 0.686 |
DOC_USP7_MATH_1 | 219 | 223 | PF00917 | 0.646 |
DOC_USP7_UBL2_3 | 204 | 208 | PF12436 | 0.573 |
DOC_USP7_UBL2_3 | 212 | 216 | PF12436 | 0.638 |
LIG_14-3-3_CanoR_1 | 128 | 136 | PF00244 | 0.529 |
LIG_BIR_III_4 | 8 | 12 | PF00653 | 0.762 |
LIG_BRCT_BRCA1_1 | 138 | 142 | PF00533 | 0.484 |
LIG_CaM_IQ_9 | 133 | 149 | PF13499 | 0.536 |
LIG_FHA_2 | 120 | 126 | PF00498 | 0.588 |
LIG_FHA_2 | 167 | 173 | PF00498 | 0.646 |
LIG_FHA_2 | 3 | 9 | PF00498 | 0.504 |
LIG_LIR_Nem_3 | 79 | 85 | PF02991 | 0.497 |
LIG_PTB_Apo_2 | 55 | 62 | PF02174 | 0.675 |
LIG_PTB_Phospho_1 | 55 | 61 | PF10480 | 0.674 |
LIG_SH2_CRK | 16 | 20 | PF00017 | 0.554 |
LIG_SH2_CRK | 61 | 65 | PF00017 | 0.709 |
LIG_SH2_NCK_1 | 16 | 20 | PF00017 | 0.703 |
LIG_SH2_NCK_1 | 40 | 44 | PF00017 | 0.647 |
LIG_SH2_NCK_1 | 61 | 65 | PF00017 | 0.678 |
LIG_SH2_STAT3 | 7 | 10 | PF00017 | 0.690 |
LIG_SH3_3 | 172 | 178 | PF00018 | 0.642 |
LIG_SH3_3 | 66 | 72 | PF00018 | 0.682 |
LIG_SH3_4 | 208 | 215 | PF00018 | 0.559 |
LIG_TRAF2_1 | 179 | 182 | PF00917 | 0.622 |
MOD_CK2_1 | 119 | 125 | PF00069 | 0.594 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.720 |
MOD_GSK3_1 | 17 | 24 | PF00069 | 0.514 |
MOD_GSK3_1 | 219 | 226 | PF00069 | 0.557 |
MOD_N-GLC_1 | 21 | 26 | PF02516 | 0.703 |
MOD_N-GLC_1 | 223 | 228 | PF02516 | 0.551 |
MOD_NEK2_1 | 136 | 141 | PF00069 | 0.537 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.508 |
MOD_OFUCOSY | 133 | 140 | PF10250 | 0.474 |
MOD_PIKK_1 | 119 | 125 | PF00454 | 0.540 |
MOD_PKA_2 | 127 | 133 | PF00069 | 0.470 |
MOD_PKA_2 | 17 | 23 | PF00069 | 0.695 |
MOD_SUMO_for_1 | 179 | 182 | PF00179 | 0.560 |
MOD_SUMO_for_1 | 184 | 187 | PF00179 | 0.544 |
MOD_SUMO_for_1 | 192 | 195 | PF00179 | 0.627 |
MOD_SUMO_rev_2 | 181 | 190 | PF00179 | 0.627 |
TRG_ENDOCYTIC_2 | 93 | 96 | PF00928 | 0.641 |
TRG_ER_diArg_1 | 109 | 111 | PF00400 | 0.678 |
TRG_NLS_MonoExtN_4 | 108 | 115 | PF00514 | 0.613 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IA54 | Leptomonas seymouri | 71% | 100% |
A0A1X0P7C1 | Trypanosomatidae | 42% | 100% |
A0A3Q8ISC2 | Leishmania donovani | 80% | 100% |
A4I6A1 | Leishmania infantum | 80% | 100% |
E9B1F6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 77% | 96% |
Q4Q6Q6 | Leishmania major | 80% | 100% |